CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by ...

Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know ...

Roche today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the cobas® Respiratory 4-flex. This is the first FDA-cleared assay utilizing Roche's innovative TAGS (Temperature ...

Thanks to vaccinations against SARS-CoV-2 in the period 2020-2024 2.533 million deaths were prevented at global level, one ...

During the study period, there were 6,879 positive SARS-CoV-2 test results reported to Fairview Employee Health from people ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus ...

The online tool CoVerage can detect and characterize SARS-CoV-2 Variants of Concern (VOCs) up to three months before their formal designation of the WHO. Since the start of the SARS-CoV-2 pandemic ...

A new study reveals that the SARS-CoV-2 nsp1 protein broadly suppresses host translation machinery in both bat and human cells.

CAMBRIDGE, MA / ACCESS Newswire / July 25, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...